30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Clover Health Investments Corp (CLOV)

Track

Over the last 90 days, Clover Health Investments Corp. has seen significant insider selling, with a net value of -$684,453.11. Executives contributed -$454,765.91 to this net sell-off. Notably, there were 19 transactions, all of which were sales, indicating a trend of insiders reducing their holdings.
Stock chart
Ticker: CLOV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Reynoso Jamie L.
CEO, Medicare Advantage
1 sale — total 100,000 USD
Planned sale 17 Jun 2026
Value US$3,130,909.18 | Price 269.03 | Shares 14,090
Proposed sale 17 Jun 2026
Value US$221,976.79 | Price 466.32 | Shares 35,241
Sale 16 Jun 2026
Value US$100,000.00 | Price 4.86 | Shares 1,000
Proposed sale 16 Jun 2026
Value US$100,000.00 | Price 4.94 | Shares 1,000
Sale 15 Jun 2026
Value US$100,000.00 | Price 4.61 | Shares 1,000
Sale 15 Jun 2026
Value US$100,000.00 | Price 4.61 | Shares 1,000
Proposed sale 15 Jun 2026
Value US$100,000.00 | Price 4.81 | Shares 1,000
Proposed sale 15 Jun 2026
Value US$100,000.00 | Price 4.81 | Shares 1,000
Planned sale 11 Jun 2026
Value US$100,000.00 | Price 4.91 | Shares 1,000
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 4.89 | Shares 1,000
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 4.89 | Shares 1,000
Planned sale 28 May 2026
Value US$879,499.74 | Price 3.99 | Shares 220,426
Proposed sale 28 May 2026
Value US$880,576.52 | Price 3.99 | Shares 220,426
Sale 18 May 2026
Value US$229,687.20 | Price 3.42 | Shares 67,160
Proposed sale 18 May 2026
Value US$229,129.77 | Price 3.41 | Shares 67,160
Proposed sale 18 May 2026
Value US$229,129.77 | Price 3.41 | Shares 67,160
Proposed sale 14 May 2026
Value US$3,057,876.45 | Price 3.45 | Shares 886,341
Sale 13 May 2026
Value US$345,097.28 | Price 3.52 | Shares 98,039
Proposed sale 13 May 2026
Value US$345,107.08 | Price 3.52 | Shares 98,039
Planned sale 18 Mar 2026
Value US$11,141.03 | Price 1.91 | Shares 5,833
Proposed sale 18 Mar 2026
Value US$11,257.69 | Price 1.93 | Shares 5,833
Sale 4 Mar 2026
Value US$379,750.00 | Price 2.17 | Shares 175,000
Proposed sale 4 Mar 2026
Value US$378,945.00 | Price 2.17 | Shares 175,000
Proposed sale 20 Jan 2026
Value US$11,676.38 | Price 2.54 | Shares 4,597
Planned sale 20 Jan 2026
Value US$11,860.26 | Price 2.58 | Shares 4,597
Proposed sale 7 Jan 2026
Value US$5,444.18 | Price 2.59 | Shares 2,102
Planned sale 7 Jan 2026
Value US$5,318.06 | Price 2.53 | Shares 2,102
Proposed sale 18 Dec 2025
Value US$12,773.80 | Price 2.60 | Shares 4,913
Planned sale 18 Dec 2025
Value US$12,822.93 | Price 2.61 | Shares 4,913
Planned sale 4 Nov 2025
Value US$108,778.30 | Price 3.58 | Shares 30,385
Proposed sale 4 Nov 2025
Value US$111,816.80 | Price 3.68 | Shares 30,385
Planned sale 17 Oct 2025
Value US$44,422.66 | Price 2.69 | Shares 16,514
Proposed sale 17 Oct 2025
Value US$44,587.80 | Price 2.70 | Shares 16,514
Proposed sale 7 Oct 2025
Value US$5,271.44 | Price 2.62 | Shares 2,012
Planned sale 7 Oct 2025
Value US$5,331.80 | Price 2.65 | Shares 2,012
Planned sale 17 Sep 2025
Value US$15,184.26 | Price 3.09 | Shares 4,914
Proposed sale 17 Sep 2025
Value US$15,331.68 | Price 3.12 | Shares 4,914
Buy 13 Aug 2025
Value US$37,555.00 | Price 2.59 | Shares 14,500
Buy 13 Aug 2025
Value US$31,200.00 | Price 2.60 | Shares 12,000
Buy 8 Aug 2025
Value US$69,396.60 | Price 2.17 | Shares 31,980
Buy 7 Aug 2025
Value US$929,600.00 | Price 2.24 | Shares 415,000
Planned sale 4 Aug 2025
Value US$19,718.47 | Price 2.89 | Shares 6,823
Proposed sale 4 Aug 2025
Value US$18,967.94 | Price 2.78 | Shares 6,823
Planned sale 23 Jul 2025
Value US$302,774.04 | Price 3.32 | Shares 91,197
Planned sale 22 Jul 2025
Value US$390,194.00 | Price 3.29 | Shares 118,600
Proposed sale 8 Jul 2025
Value US$731,250.00 | Price 3.25 | Shares 225,000
Planned sale 7 Jul 2025
Value US$5,734.20 | Price 2.85 | Shares 2,012
Proposed sale 7 Jul 2025
Value US$5,150.72 | Price 2.56 | Shares 2,012
Planned sale 3 Jul 2025
Value US$51,055.62 | Price 2.58 | Shares 19,789
Proposed sale 3 Jul 2025
Value US$51,253.51 | Price 2.59 | Shares 19,789
Planned sale 17 Jun 2025
Value US$58,487.00 | Price 2.86 | Shares 20,450
Proposed sale 17 Jun 2025
Value US$59,714.00 | Price 2.92 | Shares 20,450
Sale 7 Mar 2025
Value US$722,000.00 | Price 3.61 | Shares 200,000
Proposed sale 7 Mar 2025
Value US$744,000.00 | Price 3.72 | Shares 200,000
Sale 6 Mar 2025
Value US$276,000.00 | Price 3.68 | Shares 75,000
Proposed sale 6 Mar 2025
Value US$276,268.80 | Price 3.68 | Shares 75,000
Sale 6 Mar 2025
Value US$199,500.00 | Price 3.80 | Shares 52,500
Proposed sale 6 Mar 2025
Value US$276,268.80 | Price 3.68 | Shares 75,000
Proposed sale 5 Mar 2025
Value US$199,500.00 | Price 3.80 | Shares 52,500
Buy 9 Aug 2024
Value US$999,596.00 | Price 1.88 | Shares 531,700
Buy 17 Jun 2024
Value US$1,000,426.38 | Price 1.14 | Shares 877,567
Buy 17 May 2024
Value US$9,300.00 | Price 0.93 | Shares 10,000
Buy 16 May 2024
Value US$1,395.90 | Price 0.94 | Shares 1,485
Buy 16 May 2024
Value US$14,976.00 | Price 0.96 | Shares 15,600
Buy 14 Mar 2024
Value US$9,946.25 | Price 0.73 | Shares 13,625
Buy 14 Mar 2024
Value US$100,010.00 | Price 0.73 | Shares 137,000
Buy 6 Sep 2023
Value US$650.00 | Price 1.30 | Shares 500
Buy 6 Sep 2023
Value US$650.00 | Price 1.30 | Shares 500
Buy 6 Sep 2023
Value US$13,000.00 | Price 1.30 | Shares 10,000
Buy 11 Mar 2022
Value US$248,072.00 | Price 3.10 | Shares 80,000
Buy 3 Mar 2022
Value US$252,530.00 | Price 2.53 | Shares 100,000
Buy 22 Nov 2021
Value US$9,999,997.50 | Price 5.75 | Shares 1,739,130
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-17 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
14,090 +11.5%
269.03
US$3,130,909 		14,090 +11.5% 269.03 US$3,130,909
2026-06-17 2026-06-17 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
35,241
466.32
US$221,977 		35,241 466.32 US$221,977
2026-06-17 2026-06-16 S Sale
OLDAKOWSKI JOSEPH FRANK

VP OF FINANCE AND CONTROLLER

Officer
64,839 +43.2%
114.11
US$1,565,158 		64,839 +43.2% 114.11 US$1,565,158
2026-06-16 2026-06-16 PrS Proposed sale
Joseph Frank Oldakowski

Officer

Officer
1,000
4.94
US$100,000 		1,000 4.94 US$100,000
2026-06-16 2026-06-15 S Sale
3.2
Soares Karen

Chief Legal Officer

Officer
1,000 -0.3%
4.61
US$100,000 		1,000 -0.3% 4.61 US$100,000
2026-06-16 2026-06-15 S Sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
1,000 -0.2%
4.61
US$100,000 		1,000 -0.2% 4.61 US$100,000
2026-06-15 2026-06-15 PrS Proposed sale
3.2
Karen Soares

Officer

Officer
1,000
4.81
US$100,000 		1,000 4.81 US$100,000
2026-06-15 2026-06-15 PrS Proposed sale
Jamie Reynoso

Officer

Officer
1,000
4.81
US$100,000 		1,000 4.81 US$100,000
2026-06-11 2026-06-11 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
1,000 -0.3%
4.91
US$100,000 		1,000 -0.3% 4.91 US$100,000
2026-06-11 2026-06-11 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
1,000
4.89
US$100,000 		1,000 4.89 US$100,000
2026-06-11 2026-06-11 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
1,000
4.89
US$100,000 		1,000 4.89 US$100,000
2026-05-28 2026-05-28 PlS Planned sale
Wai Conrad

CEO, Counterpart Health

Officer
220,426 -13.7%
3.99
US$879,500 		220,426 -13.7% 3.99 US$879,500
2026-05-28 2026-05-28 PrS Proposed sale
Wai Conrad

Officer

Officer
220,426
3.99
US$880,577 		220,426 3.99 US$880,577
2026-05-19 2026-05-18 S Sale
3.1
Edwards Carladenise Armbrister
Non-Executive Director
67,160 -19.0%
3.42
US$229,687 		67,160 -19.0% 3.42 US$229,687
2026-05-18 2026-05-18 PrS Proposed sale
3.1
CARLADENISE A EDWARDS

Director

Non-Executive Director
67,160
3.41
US$229,130 		67,160 3.41 US$229,130
2026-05-18 2026-05-18 PrS Proposed sale
3.1
CARLADENISE A EDWARDS

Director

Non-Executive Director
67,160
3.41
US$229,130 		67,160 3.41 US$229,130
2026-05-14 2026-05-14 PrS Proposed sale
4.0
Kuipers Peter J.

former CFO
886,341
3.45
US$3,057,876 		886,341 3.45 US$3,057,876
2026-05-13 2026-05-13 S Sale
2.4
Priest Brady Patrick

CEO of Clover Care Services

Officer
98,039 -4.6%
3.52
US$345,097 		98,039 -4.6% 3.52 US$345,097
2026-05-13 2026-05-13 PrS Proposed sale
2.4
BRADY PRIEST

Officer

Officer
98,039
3.52
US$345,107 		98,039 3.52 US$345,107
2026-03-18 2026-03-18 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
5,833 -0.2%
1.91
US$11,141 		5,833 -0.2% 1.91 US$11,141
2026-03-18 2026-03-18 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
5,833
1.93
US$11,258 		5,833 1.93 US$11,258
2026-03-05 2026-03-04 S Sale
2.4
Priest Brady Patrick

CEO of Home Care

Officer
175,000 -8.1%
2.17
US$379,750 		175,000 -8.1% 2.17 US$379,750
2026-03-04 2026-03-04 PrS Proposed sale
2.4
BRADY PRIEST

Officer

Officer
175,000
2.17
US$378,945 		175,000 2.17 US$378,945
2026-01-20 2026-01-20 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
4,597
2.54
US$11,676 		4,597 2.54 US$11,676
2026-01-20 2026-01-20 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
4,597 -0.2%
2.58
US$11,860 		4,597 -0.2% 2.58 US$11,860
2026-01-07 2026-01-07 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
2,102
2.59
US$5,444 		2,102 2.59 US$5,444
2026-01-07 2026-01-07 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
2,102 -0.1%
2.53
US$5,318 		2,102 -0.1% 2.53 US$5,318
2025-12-18 2025-12-18 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
4,913
2.60
US$12,774 		4,913 2.60 US$12,774
2025-12-18 2025-12-18 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
4,913 -0.2%
2.61
US$12,823 		4,913 -0.2% 2.61 US$12,823
2025-11-05 2025-11-04 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
30,385 -1.1%
3.58
US$108,778 		30,385 -1.1% 3.58 US$108,778
2025-11-04 2025-11-04 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
30,385
3.68
US$111,817 		30,385 3.68 US$111,817
2025-10-21 2025-10-17 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
16,514 -0.6%
2.69
US$44,423 		16,514 -0.6% 2.69 US$44,423
2025-10-17 2025-10-17 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
16,514
2.70
US$44,588 		16,514 2.70 US$44,588
2025-10-07 2025-10-07 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
2,012
2.62
US$5,271 		2,012 2.62 US$5,271
2025-10-07 2025-10-07 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
2,012 -0.1%
2.65
US$5,332 		2,012 -0.1% 2.65 US$5,332
2025-09-19 2025-09-17 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
4,914 -0.2%
3.09
US$15,184 		4,914 -0.2% 3.09 US$15,184
2025-09-17 2025-09-17 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
4,914
3.12
US$15,332 		4,914 3.12 US$15,332
2025-08-14 2025-08-13 B Purchase
3.5
Loengard Anna U
Non-Executive Director
14,500 +96.0%
2.59
US$37,555 		14,500 +96.0% 2.59 US$37,555
2025-08-14 2025-08-13 B Purchase
3.5
Loengard Anna U
Non-Executive Director
12,000 +76.9%
2.60
US$31,200 		12,000 +76.9% 2.60 US$31,200
2025-08-08 2025-08-08 B Purchase
4.1
Garipalli Vivek
Non-Executive Director Large shareholder
31,980 +1.8%
2.17
US$69,397 		31,980 +1.8% 2.17 US$69,397
2025-08-08 2025-08-07 B Purchase
4.1
Garipalli Vivek
Non-Executive Director Large shareholder
415,000 +29.4%
2.24
US$929,600 		415,000 +29.4% 2.24 US$929,600
2025-08-06 2025-08-04 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
6,823 -0.2%
2.89
US$19,718 		6,823 -0.2% 2.89 US$19,718
2025-08-04 2025-08-04 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
6,823
2.78
US$18,968 		6,823 2.78 US$18,968
2025-07-24 2025-07-23 PlS Planned sale
Wai Conrad

CEO, Counterpart Health

Officer
91,197 -6.1%
3.32
US$302,774 		91,197 -6.1% 3.32 US$302,774
2025-07-24 2025-07-22 PlS Planned sale
Wai Conrad

CEO, Counterpart Health

Officer
118,600 -7.4%
3.29
US$390,194 		118,600 -7.4% 3.29 US$390,194
2025-07-08 2025-07-08 PrS Proposed sale
Wai Conrad

Officer

Officer
225,000
3.25
US$731,250 		225,000 3.25 US$731,250
2025-07-08 2025-07-07 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
2,012 -0.1%
2.85
US$5,734 		2,012 -0.1% 2.85 US$5,734
2025-07-07 2025-07-07 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
2,012
2.56
US$5,151 		2,012 2.56 US$5,151
2025-07-08 2025-07-03 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
19,789 -0.6%
2.58
US$51,056 		19,789 -0.6% 2.58 US$51,056
2025-07-03 2025-07-03 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
19,789
2.59
US$51,254 		19,789 2.59 US$51,254
2025-06-18 2025-06-17 PlS Planned sale
Reynoso Jamie L.

CEO, Medicare Advantage

Officer
20,450 -0.6%
2.86
US$58,487 		20,450 -0.6% 2.86 US$58,487
2025-06-17 2025-06-17 PrS Proposed sale
JAMIE REYNOSO

Officer

Officer
20,450
2.92
US$59,714 		20,450 2.92 US$59,714
2025-03-11 2025-03-07 S Sale
3.1
Edwards Carladenise Armbrister
Non-Executive Director
200,000 -42.3%
3.61
US$722,000 		200,000 -42.3% 3.61 US$722,000
2025-03-07 2025-03-07 PrS Proposed sale
3.1
Edwards Carladenise Armbrister

Director

Non-Executive Director
200,000
3.72
US$744,000 		200,000 3.72 US$744,000
2025-03-07 2025-03-06 S Sale
2.4
Priest Brady Patrick

CEO of Home Care

Officer
75,000 -3.0%
3.68
US$276,000 		75,000 -3.0% 3.68 US$276,000
2025-03-07 2025-03-06 S Sale
3.2
Soares Karen

General Counsel & Secretary

Officer
52,500 -3.9%
3.80
US$199,500 		52,500 -3.9% 3.80 US$199,500
2025-03-06 2025-03-06 PrS Proposed sale
2.4
Priest Brady Patrick

Officer

Officer
75,000
3.68
US$276,269 		75,000 3.68 US$276,269
2025-03-06 2025-03-06 PrS Proposed sale
3.2
Soares Karen

Officer

Officer
75,000
3.68
US$276,269 		75,000 3.68 US$276,269
2025-03-06 2025-03-05 PrS Proposed sale
3.2
Soares Karen

Officer

Officer
52,500
3.80
US$199,500 		52,500 3.80 US$199,500
2024-08-13 2024-08-09 B Purchase
4.1
Garipalli Vivek
Non-Executive Director Large shareholder
531,700 +60.6%
1.88
US$999,596 		531,700 +60.6% 1.88 US$999,596
2024-06-20 2024-06-17 B Purchase
4.1
Garipalli Vivek
Non-Executive Director Large shareholder
877,567 +inf%
1.14
US$1,000,426 		877,567 +inf% 1.14 US$1,000,426
2024-05-20 2024-05-17 B Purchase
3.5
Loengard Anna U
Non-Executive Director
10,000 +inf%
0.93
US$9,300 		10,000 +inf% 0.93 US$9,300
2024-05-20 2024-05-16 B Purchase
3.5
Loengard Anna U
Non-Executive Director
1,485 +10.9%
0.94
US$1,396 		1,485 +10.9% 0.94 US$1,396
2024-05-20 2024-05-16 B Purchase
3.5
Loengard Anna U
Non-Executive Director
15,600 +inf%
0.96
US$14,976 		15,600 +inf% 0.96 US$14,976
2024-03-18 2024-03-14 B Purchase
3.5
Loengard Anna U
Non-Executive Director
13,625 +908.3%
0.73
US$9,946 		13,625 +908.3% 0.73 US$9,946
2024-03-18 2024-03-14 B Purchase
3.5
Loengard Anna U
Non-Executive Director
137,000 +34.1%
0.73
US$100,010 		137,000 +34.1% 0.73 US$100,010
2023-09-08 2023-09-06 B Purchase
3.5
Loengard Anna U
Non-Executive Director
500 +50.0%
1.30
US$650 		500 +50.0% 1.30 US$650
2023-09-08 2023-09-06 B Purchase
3.5
Loengard Anna U
Non-Executive Director
500 +62.5%
1.30
US$650 		500 +62.5% 1.30 US$650
2023-09-08 2023-09-06 B Purchase
3.5
Loengard Anna U
Non-Executive Director
10,000 +inf%
1.30
US$13,000 		10,000 +inf% 1.30 US$13,000
2022-03-15 2022-03-11 B Purchase
1.8
SHAPIRO LEE
Non-Executive Director
80,000 +295.2%
3.10
US$248,072 		80,000 +295.2% 3.10 US$248,072
2022-03-04 2022-03-03 B Purchase
1.8
Clinton Chelsea
Non-Executive Director
100,000 +inf%
2.53
US$252,530 		100,000 +inf% 2.53 US$252,530
2021-11-24 2021-11-22 B Purchase
2.9
Palihapitiya Chamath

See Remarks

Large shareholder
1,739,130 +inf%
5.75
US$9,999,998 		1,739,130 +inf% 5.75 US$9,999,998
Explore more

More insider trading research around Clover Health Investments Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America